Article Listing - Actelion’s third-quarter 2010 results miss consensus forecast

PROFITS UP AT ITALIAN SORIN BIOMEDICA IN 1991

6 April 1992

Sorin Biomedica made net profits in 1991 of 12.3 billion lire ($9.9 billion), up from 11 billion lire in the...

GENENTECH REBUFFS ISIS-3 AND AWAITS GUSTO

6 April 1992

With the formal publication in The Lancet last week of the results of the ISIS-3 thrombolytic product trial, the major...

CORTECS' NSAID TARGETING STRATEGY

6 April 1992

Researchers at UK-based Cortecs Limited have published results of studies in volunteers concerning its technology aimed at improving the bioavailability...

AUSTRALIAN DRUG PROMOTION STUDY

6 April 1992

In Australia, a parliamentary report from the House of Representatives concludes that there is no evidence that hospitality provided...

BAYER DIAGNOSTICS' NEW INSTRUMENT

6 April 1992

Bayer Diagnostics has launched the Ames Clinitek 200+, benchtop, semi-automated urine chemistry analyser for moderate to large volume urine testing....

ENZON AND CYTOCLONAL PHARMACEUTICS

6 April 1992

Enzon Inc has entered into an agreement with Cytoclonal Pharmaceutics to apply the former's drug delivery technologies to Cytoclonal products...

PFIZER'S DIFLUCAN

6 April 1992

Prophylactic administration of Pfizer's Diflucan (fluconazole) to recipients of autologous bone marrow transplants reduces the incidence of both systemic and...